Biomedical features and therapeutic potential of rosmarinic acid.
Saba NoorTaj MohammadMalik Abdul RubAli RazaNaved AzumDharmendra Kumar YadavM D Imtaiyaz HassanAbdullah M AsiriPublished in: Archives of pharmacal research (2022)
For decades, the use of secondary metabolites of various herbs has been an attractive strategy in combating human diseases. Rosmarinic acid (RA) is a bioactive phenolic compound commonly found in plants of Lamiaceae and Boraginaceae families. RA is biosynthesized using amino acids tyrosine and phenylalanine via enzyme-catalyzed reactions. However, the chemical synthesis of RA involves an esterification reaction between caffeic acid and 3,4-dihydroxy phenyl lactic acid contributing two phenolic rings to the structure of RA. Several studies have ascertained multiple therapeutic benefits of RA in various diseases, including cancer, diabetes, inflammatory disorders, neurodegenerative disorders, and liver diseases. Many previous scientific papers indicate that RA can be used as an anti-plasmodic, anti-viral and anti-bacterial drug. In addition, due to its high anti-oxidant capacity, this natural polyphenol has recently gained attention for its possible application as a nutraceutical compound in the food industry. Here we provide state-of-the-art, flexible therapeutic potential and biomedical features of RA, its implications and multiple uses. Along with various valuable applications in safeguarding human health, this review further summarizes the therapeutic advantages of RA in various human diseases, including cancer, diabetes, neurodegenerative diseases. Furthermore, the challenges associated with the clinical applicability of RA have also been discussed.
Keyphrases
- rheumatoid arthritis
- disease activity
- ankylosing spondylitis
- human health
- endothelial cells
- type diabetes
- cardiovascular disease
- interstitial lung disease
- papillary thyroid
- lactic acid
- systemic lupus erythematosus
- oxidative stress
- squamous cell carcinoma
- sars cov
- amino acid
- working memory
- insulin resistance
- induced pluripotent stem cells
- lymph node metastasis
- squamous cell
- drug induced
- case control